SCN4A and periodic paralysis: Clinical and electromyographical features reveal that mutations in the encoding gene SCN4A of Nav1.4 can trigger hyperkalemic periodic paralysis and paramyotonia congenital, while sodium channel myotonias may produce gain-of-function changes [4], but loss-of-function mutations may induce hypokalamic periodic paralysis and myasthenic weakness [5].